News

The Brief: Imagining the Buildings of Tomorrow “Design a building of the future. It has to be a place where people can live, work or study. It can be any size, shape or colour, and made of any material you want.” Inspiring the Next Generation of STEM Leaders That is the brief for our BUILDING BLOCKS Schools Challenge, given to 240 Year 5 students. It’s a competition that wraps around our acclaimed BUILDING BLOCKS Insights event, where 9 and 10-year-olds from local sch

The National Innovation Centre for Data (NICD), based at The Catalyst at Newcastle Helix, has revealed the findings of a new independent Economic Impact Report, highlighting the significant contribution it is making to the North East and wider UK economy. The findings were shared at a breakfast briefing at The Catalyst, bringing together the NICD community to celebrate its achievements to date and look ahead to the Centre’s next chapter. And there was plenty to celebrate. I

The BUILDING BLOCKS programme continues to grow at the Innovation District of Newcastle Helix. Following the success of last year’s ground-breaking pilot, we were delighted to host a fresh cohort of enthusiastic businesses and students for our Work Experience Week 2026. In the last week of their school year, 24 Year 10 students from across Tyneside were welcomed to Newcastle Helix for a STEM-inspired experience, with a difference. Taking the form of a structured work placemen

The Key, The Spark, The Biosphere and The Catalyst at Newcastle Helix Three of Newcastle Helix's landmark buildings are helping to shape the future of smart building management as part of a major European research and development project. The Core, The Spark and the Urban Sciences Building are now entering the testing phase of Project WILSON, a Horizon Europe EU-funded initiative bringing together businesses, universities and research organisations from across Europe to devel

Data with Real-World Impact For Esther Gillespie, CEO & Co-founder at Jumping Rivers, the most exciting projects are those that create meaningful impact, whether that's improving business processes, increasing efficiencies or delivering health and environmental benefits. One example is the team's work with the water industry, helping organisations make sense of vast amounts of time-series data collected from multiple sources across regions and across the country. The challeng

Iksuda Therapeutics, a Newcastle Helix-based biotechnology company has reached a key step in the journey from laboratory research to patient care. Iksuda Therapeutics has received clearance from the US Food and Drug Administration (FDA) to begin human clinical trials of IKS04, a new cancer treatment being developed for gastrointestinal cancers, including colorectal, gastric and pancreatic cancers. The clearance follows approval of the company's Investigational New Drug (IND)